|
MechanismCD11a antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date27 Oct 2003 |
100 Clinical Results associated with Serono Europe Limited
0 Patents (Medical) associated with Serono Europe Limited
100 Deals associated with Serono Europe Limited
100 Translational Medicine associated with Serono Europe Limited